Alpha-Defensins (HNP-1 to HNP-4, HD-5, HD-6)

Alpha-defensins are 29-35 amino acid cysteine-rich antimicrobial peptides stored in neutrophil azurophilic granules (HNP-1 to HNP-4) and Paneth cells (HD-5, HD-6), forming the first line of innate immune defense through membrane pore formation and immunomodulation.

Alpha-defensins are a family of small (29-35 amino acid), cysteine-rich cationic antimicrobial peptides that constitute a major component of human innate immunity. The six human alpha-defensins divide into two functional groups: human neutrophil peptides HNP-1 through HNP-4, stored at high concentrations (~5-7% of total protein) in the azurophilic granules of neutrophils, and human enteric defensins HD-5 and HD-6, produced by Paneth cells at the base of small intestinal crypts.

Overview

Alpha-defensins were first isolated from human neutrophils by Selsted, Harwig, and Lehrer in 1980-1985, establishing them as a major class of antimicrobial peptides in mammalian innate immunity. HNP-1, HNP-2, and HNP-3 differ by only a single N-terminal amino acid (alanine, no residue, and aspartate, respectively), while HNP-4 is the most divergent and most potent antibacterial of the neutrophil defensins. Together, HNP-1 to HNP-3 comprise approximately 30-50% of the total protein content of azurophilic granules, reaching concentrations exceeding 10 mg/mL within the phagolysosome upon degranulation.

The enteric defensins HD-5 and HD-6 are produced exclusively by Paneth cells and secreted into the intestinal crypt lumen, where they regulate the composition of the intestinal microbiome and defend against enteric pathogens. HD-5 is synthesized as a 94-amino acid propeptide and processed by trypsin to the mature 32-residue form. HD-6 is unique among defensins in that its primary antimicrobial mechanism involves formation of self-assembling nanonets that physically entrap bacteria rather than killing them through membrane disruption Chu et al. (2012).

Mechanism of Action

Alpha-defensins employ multiple antimicrobial mechanisms depending on the specific isoform:

  • Membrane pore formation (HNP-1 to HNP-4): Neutrophil defensins bind to anionic microbial membranes through electrostatic interactions, oligomerize, and form transmembrane pores that cause ion leakage, membrane depolarization, and cell death. The dimeric and higher-order oligomeric structures are essential for pore activity Hill et al. (1991).
  • Self-assembling nanonets (HD-6): Unlike other defensins, HD-6 does not directly kill bacteria but instead polymerizes upon contact with bacterial surfaces to form ordered fibrils and nanonets that physically entrap microorganisms, preventing mucosal translocation and systemic invasion Chu et al. (2012).
  • Trypsin-dependent activation (HD-5): HD-5 is stored as an inactive propeptide in Paneth cell granules and activated by trypsin cleavage upon secretion into the intestinal crypt lumen. Mature HD-5 kills bacteria through direct membrane disruption and also neutralizes bacterial toxins Ghosh et al. (2002).
  • Lectin-like activity: HD-5 binds to specific glycoproteins on microbial surfaces and can block viral entry by cross-linking surface lectins. This mechanism underlies HD-5's inhibition of adenovirus and papillomavirus infections Smith & Bhatt (2011).
  • Immunomodulation: HNP-1 to HNP-3 recruit monocytes, T cells, and immature dendritic cells through CCR6-mediated chemotaxis, bridging innate and adaptive immunity. They also enhance phagocytosis, stimulate cytokine production, and modulate complement activation Yang et al. (1999).

Reconstitution Calculator

Reconstitution Calculator

Calculate your peptide dosing

Draw Volume
0.100mL
Syringe Units
10units
Concentration
2,500mcg/mL
Doses / Vial
20doses
Vial Total
5mg
Waste / Vial
0mcg
Syringe Cap.
100units · 1mL
How to reconstitute
Gather & prepare
1/6Gather & prepare

Set up a clean workspace with all supplies ready.

1.Wash hands thoroughly, put on disposable gloves
2.Your 5mg peptide vial (lyophilized powder)
3.Bacteriostatic water (you'll need 2mL)
4.A 3–5mL syringe with 21–25 gauge needle for reconstitution
5.Alcohol swabs (70% isopropyl)
Use bacteriostatic water (0.9% benzyl alcohol) for multi-dose vials. Sterile water is only safe for single-use.
Supply Planner

7x / week for weeks

·
40%
2vials
28 doses20 days/vial12 leftover
Cost Breakdown
Vial price
$0.00per dose
$0.00 /week$0 /month
Store 2-8°C30 day shelf lifeSwirl gentlyFor research purposes only

Research

Defensin Structure and the Beta-Sheet Fold

The three-dimensional structures of alpha-defensins reveal a highly conserved fold: a triple-stranded antiparallel beta-sheet stabilized by three disulfide bonds. This rigid framework creates an amphipathic molecule with a cationic surface for membrane binding and a hydrophobic core for structural stability. Hill et al. solved the crystal structure of HNP-3, revealing that defensins form dimers that further assemble into higher-order oligomers — a process critical for membrane pore formation. The dimeric basket-like structure creates a polar channel that can span the lipid bilayer Hill et al. (1991).

Neutrophil Defensins and Antimicrobial Defense

The neutrophil defensins HNP-1 to HNP-4 are among the most abundant antimicrobial effectors in human innate immunity. Upon neutrophil activation and degranulation, defensins are released into the phagolysosome at concentrations sufficient to kill ingested bacteria within minutes. Lehrer et al. established that HNP-1 to HNP-3 exhibit broad-spectrum bactericidal activity against gram-positive and gram-negative bacteria, fungi, and enveloped viruses at micromolar concentrations. HNP-4 is the most potent antibacterial defensin but is present at lower concentrations (~1% of neutrophil defensins) Wilde et al. (1989).

Enteric Defensins and Intestinal Homeostasis (HD-5/HD-6)

HD-5 and HD-6 are critical regulators of intestinal microbial ecology. Paneth cells at the crypt base secrete defensins into the intestinal lumen in response to bacterial products (muramyl dipeptide, LPS) and cholinergic stimulation. Transgenic mice expressing human HD-5 in Paneth cells are protected against oral challenge with Salmonella typhimurium, demonstrating the in vivo antimicrobial importance of enteric defensins Salzman et al. (2003). Conversely, Paneth cell defensin deficiency, as seen in ileal Crohn's disease, is associated with altered microbiome composition and increased susceptibility to bacterial invasion Wehkamp et al. (2005).

Cancer Biomarker Potential

Elevated plasma and tissue levels of alpha-defensins have been reported in multiple cancers, with particular interest in colorectal cancer. Albrethsen et al. (2005) identified HNP-1 to HNP-3 as significantly elevated in the serum of colorectal cancer patients compared to healthy controls using SELDI-TOF mass spectrometry. The defensin elevation likely reflects tumor-associated neutrophil infiltration and inflammation rather than tumor-derived expression. While alpha-defensin levels alone lack sufficient specificity for standalone diagnostic use, they show promise as components of multi-marker panels for early colorectal cancer detection Albrethsen et al. (2005).

HIV-1 Inhibition by HNP-1

Chang et al. (2005) identified alpha-defensins HNP-1 to HNP-3 as a major component of the CD8+ T cell antiviral factor (CAF) responsible for suppression of HIV-1 replication. HNP-1 inhibits HIV-1 at multiple stages: direct virucidal activity through disruption of the viral envelope, blocking of viral entry by interfering with gp120-CD4 binding, and inhibition of post-entry viral replication steps. Elevated alpha-defensin levels have been associated with slower HIV-1 disease progression in long-term non-progressors Chang et al. (2005). Subsequent work showed that the HIV-inhibitory activity requires the native disulfide-bonded structure and is enhanced by defensin dimerization Demirkhanyan et al. (2012).

Safety Profile

Alpha-defensins are endogenous peptides with well-characterized physiological roles, but their safety profile reflects the potency of their biological activities:

  • Concentration-dependent cytotoxicity: At high concentrations (>50 μg/mL), HNP-1 to HNP-3 exhibit cytotoxicity toward mammalian epithelial cells and endothelial cells, contributing to tissue damage during excessive neutrophil activation.
  • Pro-inflammatory amplification: Elevated defensin levels in chronic inflammatory conditions (rheumatoid arthritis, vasculitis, sepsis) amplify inflammation through chemokine induction, complement activation, and mast cell degranulation.
  • Intestinal barrier disruption: Paradoxically, excessive alpha-defensin production or dysregulated processing can disrupt intestinal barrier integrity, potentially exacerbating inflammatory bowel disease.
  • Coagulation effects: HNP-1 promotes fibrinolysis inhibition and platelet activation, potentially contributing to thrombotic complications in sepsis and severe inflammation.
  • Autoimmune implications: Alpha-defensins have been detected in atherosclerotic plaques and synovial fluid of rheumatoid arthritis patients, suggesting roles in chronic inflammatory and autoimmune pathology.
  • Endogenous regulation: Normal defensin levels are tightly regulated through controlled neutrophil degranulation and Paneth cell secretion, with clearance primarily through renal filtration.

Pharmacokinetic Profile

Alpha-Defensins (HNP-1 to HNP-4, HD-5, HD-6) — Pharmacokinetic Curve

N/A (endogenous); experimental: topical, intravenous (preclinical)
0%25%50%75%100%0m3h6h9h12h15hTimeConcentration (% peak)T_max 1.2hT_1/2 3h
Half-life: 3hT_max: 1.2hDuration shown: 15h

Quick Start

Route
N/A (endogenous); experimental: topical, intravenous (preclinical)

Molecular Structure

2D Structure
Alpha-Defensins (HNP-1 to HNP-4, HD-5, HD-6) molecular structure
Molecular Properties
Formula
C212H350N56O78S
Weight
4963 Da
PubChem CID
16132341
Exact Mass
4962.4930 Da
LogP
-43.5
TPSA
2250 Ų
H-Bond Donors
72
H-Bond Acceptors
88
Rotatable Bonds
180
Complexity
12200
Identifiers (SMILES, InChI)
InChI
InChI=1S/C212H350N56O78S/c1-16-106(7)166(261-190(323)131(64-75-160(292)293)231-172(305)109(10)228-174(307)134(78-91-347-15)245-196(329)140(98-165(302)303)255-201(334)147-53-39-88-266(147)209(342)135(52-29-38-87-221)250-197(330)139(97-164(300)301)254-198(331)143(100-269)229-113(14)276)204(337)246-129(62-73-158(288)289)187(320)233-118(47-24-33-82-216)179(312)252-137(94-114-42-19-18-20-43-114)194(327)253-138(96-163(298)299)195(328)237-121(50-27-36-85-219)181(314)258-144(101-270)199(332)239-119(48-25-34-83-217)178(311)251-136(92-104(3)4)193(326)236-116(45-22-31-80-214)175(308)235-122(51-28-37-86-220)189(322)263-168(110(11)273)207(340)249-133(66-77-162(296)297)192(325)264-169(111(12)274)206(339)248-126(58-69-152(224)279)184(317)243-128(61-72-157(286)287)186(319)234-120(49-26-35-84-218)180(313)256-142(95-153(225)280)211(344)268-90-40-54-148(268)202(335)257-141(93-105(5)6)210(343)267-89-41-55-149(267)203(336)259-145(102-271)200(333)238-117(46-23-32-81-215)177(310)244-132(65-76-161(294)295)191(324)265-170(112(13)275)208(341)262-167(107(8)17-2)205(338)247-130(63-74-159(290)291)188(321)241-125(57-68-151(223)278)183(316)242-127(60-71-156(284)285)185(318)232-115(44-21-30-79-213)176(309)240-124(56-67-150(222)277)173(306)227-108(9)171(304)226-99-154(281)230-123(59-70-155(282)283)182(315)260-146(103-272)212(345)346/h18-20,42-43,104-112,115-149,166-170,269-275H,16-17,21-41,44-103,213-221H2,1-15H3,(H2,222,277)(H2,223,278)(H2,224,279)(H2,225,280)(H,226,304)(H,227,306)(H,228,307)(H,229,276)(H,230,281)(H,231,305)(H,232,318)(H,233,320)(H,234,319)(H,235,308)(H,236,326)(H,237,328)(H,238,333)(H,239,332)(H,240,309)(H,241,321)(H,242,316)(H,243,317)(H,244,310)(H,245,329)(H,246,337)(H,247,338)(H,248,339)(H,249,340)(H,250,330)(H,251,311)(H,252,312)(H,253,327)(H,254,331)(H,255,334)(H,256,313)(H,257,335)(H,258,314)(H,259,336)(H,260,315)(H,261,323)(H,262,341)(H,263,322)(H,264,325)(H,265,324)(H,282,283)(H,284,285)(H,286,287)(H,288,289)(H,290,291)(H,292,293)(H,294,295)(H,296,297)(H,298,299)(H,300,301)(H,302,303)(H,345,346)/t106-,107-,108-,109-,110+,111+,112+,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,139-,140-,141-,142-,143-,144-,145-,146-,147-,148-,149-,166-,167-,168-,169-,170-/m0/s1
InChIKeyUGPMCIBIHRSCBV-XNBOLLIBSA-N

Research Protocols

topical

Administered via topical.

GoalDoseFrequency
General Research Protocol50 μgPer protocol

oral

Transgenic mice expressing human HD-5 in Paneth cells are protected against oral challenge with Salmonella typhimurium, demonstrating the in vivo antimicrobial importance of enteric defensins [Salzman et al.

GoalDoseFrequency
General Research Protocol50 μgPer protocol

intravenous Injection

Administered via intravenous injection.

GoalDoseFrequency
Concentration-dependent cytotoxicity50 μgPer protocol

Interactions

Peptide Interactions

LL-37 (Cathelicidin)synergistic

Alpha-defensins and cathelicidin LL-37 are co-stored in neutrophil granules and exhibit synergistic antimicrobial activity. They disrupt microbial membranes through complementary mechanisms—defensins form pore-like structures while LL-37 operates via carpet-model disruption. Combined MIC values are significantly lower than either alone (Nagaoka et al., 2000; Hancock & Sahl, 2006).

Thymosin Alpha-1synergistic

Thymosin alpha-1 enhances innate immune function by promoting dendritic cell maturation and TLR signaling, which upregulates endogenous antimicrobial peptide expression including defensins. The combination provides both direct antimicrobial activity (defensins) and enhanced immune surveillance (thymalfasin) (Romani et al., 2006).

What to Expect

What to Expect

Onset

Effects begin within hours of administration based on half-life of ~2-4 hours (circulating; rapidly cleared renally)

Daily Use

Due to short half-life (~2-4 hours (circulating; rapidly cleared renally)), effects are expected per-dose; consistent daily administration maintains...

Ongoing

Regular administration schedule required; effects are dose-dependent and do not persist between doses

Quality Indicators

What to look for

  • Extensive peer-reviewed research base

Frequently Asked Questions

References (18)

  1. [13]
    Demirkhanyan LH, Marin M, Padilla-Parra S, et al Multifaceted mechanisms of HIV-1 entry inhibition by human alpha-defensin J Biol Chem (2012)
  2. [17]
  3. [18]
  4. [10]
  5. [8]
  6. [12]
    Deirmengian C, Kardos K, Kilmartin P, et al Diagnosing periprosthetic joint infection: has the era of the biomarker arrived? Clin Orthop Relat Res (2014)
  7. [1]
    Selsted ME, Harwig SS, Ganz T, et al Primary structures of three human neutrophil defensins J Clin Invest (1985)
  8. [2]
  9. [3]
  10. [5]
    Chang TL, Vargas J, DelPortillo A, Klotman ME Dual role of alpha-defensin-1 in anti-HIV-1 innate immunity J Clin Invest (2005)
  11. [6]
  12. [7]
    Wehkamp J, Salzman NH, Porter E, et al Reduced Paneth cell alpha-defensins in ileal Crohn's disease Proc Natl Acad Sci USA (2005)
  13. [4]
  14. [9]
    Ghosh D, Porter E, Shen B, et al Paneth cell trypsin is the processing enzyme for human defensin-5 Nat Immunol (2002)
  15. [16]
    Zhao L, Lu W — Defensins in innate immunity Curr Opin Hematol (2023)
  16. [11]
    Smith JG, Bhatt A Human alpha-defensin 5 (HD5) prevents adenovirus infection by blocking receptor engagement PLoS Pathog (2011)
  17. [14]
    Xu D, Lu W — Alpha-defensins: structure, function, and new insights into antimicrobial mechanism Cell Mol Life Sci (2023)
  18. [15]
    Sankaran-Walters S et al — Enteric defensin dysregulation and the gut microbiome in HIV disease progression Mucosal Immunol (2022)
Updated 2026-03-0813 citationsSources: peptide-wiki-mdx, pubchem, peptide-wiki-mdx-v2

On this page